bioRxivPharmacology & Toxicology
Attenuated Dopamine Receptor Signaling in Nucleus Accumbens Core in a Rat Model of Chemically-Induced Neuropathy
D. E. Selley, M. F. Lazenka, L. J. Sim-Selley, D. N. Potter, E. H. Chartoff, W. A. Carlezon, S. S. Negus
Abstract
Neuropathy is major source of chronic pain that can be caused by mechanically or chemically induced nerve injury. Previous work in a rat model of neuropathic pain demonstrated that bilateral formalin injection into the hind paws produced mechanical hypersensitivity (allodynia) and depressed responding for intracranial self-stimulation (ICSS). To determine whether neuropathy alters dopamine receptor responsiveness in mesolimbic brain regions, we examined dopamine D1-like and D2-like receptor (D1/2R) signaling and expression in male rats 14 days after bilateral intraplantar formalin injections into both rear paws. D2R-mediated G-protein activation and expression of the D2R long, but not short, isoform were reduced in nucleus accumbens (NAc) core, but not in NAc shell, caudate-putamen (CPu) or ventral tegmental area (VTA) of formalin-compared to saline-treated rats. In addition, D1R-stimulated adenylyl cyclase (AC) activity was also reduced in NAc core, but not in NAc shell or prefrontal cortex, of formalin-treated rats, whereas D1R expression was unaffected. Expression of other proteins involved in dopamine neurotransmission, including dopamine uptake transporter (DAT) and tyrosine hydroxylase (TH), were unaffected by formalin treatment. In behavioral tests, the effects of D2R agonists on ICSS were attenuated in formalin-treated rats, whereas the effects of D1R agonists were unchanged. These results indicate that intraplantar formalin as a model of chemically induced neuropathy produces attenuation of highly specific DA receptor signaling processes in NAc core of male rats.
- organism: rat
- assay: proteomics
- research focus: cell signaling & trafficking
- research focus: host-pathogen & immune response
- approach: experimental assay
- approach: wet-lab / biochemical assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- D1R-specific modulation of ACC mitigates chronic neuropathic pain
Yatika Chaudhary, Srividya Subash, … Arnab Barik·bioRxiv·Jan 3, 2026
- Neuropathic Pain Linked to Defective Dopaminergic Inhibition in Anterior Cingulate Cortex
Kevin Lançon, Edita Navratilova, … Philippe Séguéla·bioRxiv·May 9, 2020
- Reduced SK channel control of mesolimbic dopamine neuron firing drives reward seeking adaptations in chronic pain
Jeremy M. Thompson, Robert D. Graham, … Meaghan C. Creed·bioRxiv·Oct 6, 2025
- Dorsal Hippocampal Activation Suppresses Neuropathic Pain Behaviors: Chronic pain as extinction-resistant pain-related memory traces
Wei Xuhong, W. Ren, … A. Vania Apkarian·bioRxiv·Mar 30, 2018
- Chronic neuropathic pain alters reversal learning without generally impacting sucrose self-administration in mice
A.A. Borges, Mitchell A. Nothem, … Jacqueline M. Barker·Behavioural Brain ResearchPeer-reviewed·May 14, 2026
- Inhibitory effects of dopamine agonists on pain-responsive neurons in the central nucleus of the amygdala
Robert J. Heuermann, Robert W. Gereau·Journal of NeurophysiologyPeer-reviewed·May 27, 2025